Article

Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19

2023-12-24

Abstract excerpt

<h4>Background</h4> Data on Covid-19 booster vaccinations and subsequent infections on immune responses in the immunocompromised is limited. We studied antibody responses after the fourth dose and subsequent breakthrough infection to define patient groups benefiting most from boosters. <h4>Methods</h4> In Finland, fourth vaccine (booster) doses were first recommended for severely immunocompromised individuals, who...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 47b5f4b6-971b-57e1-890f-ce75ea05f665
DOI: 10.1101/2023.12.21.23300374

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19DOI 10.1101/2023.12.21.23300374Read

Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)Semantic proximity Read

Determinants of Antibody Responses to Two Doses of ChAdOx1 nCoV-19 or Bnt162b2 and a Subsequent Booster Dose of BNT162b2 or mRNA-1273: Population-Based Cohort Study (COVIDENCE UK)Semantic proximity Read

Immune Compromising Conditions Impair SARS-CoV-2 Vaccine Humoral Immunogenicity Despite Multiple Booster DosesSemantic proximity Read

A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studySemantic proximity Read

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trialSemantic proximity Read

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in EnglandSemantic proximity Read

Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort studySemantic proximity Read

Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Immunocompromised Adults in Greece: Necessity of a Fourth DoseSemantic proximity Read

Anti-spike antibody trajectories in individuals previously immunised with BNT162b2 or ChAdOx1 following a BNT162b2 booster doseSemantic proximity Read

Antibody response against SARS-CoV-2 spike protein in people with HIV after COVID-19 vaccinationSemantic proximity Read

Immunity response against mild-to-moderate breakthrough COVID-19Semantic proximity Read

Mechanistic models of humoral kinetics following COVID-19 vaccinationSemantic proximity Read